Balyasny Asset Management LLC Boston Scientific Corp Call Options Transaction History

Balyasny Asset Management LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $218,879 - $252,000	3,000 Added 14.22%	24,100 $2.02 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $1.41 Million - $1.63 Million	-21,000 Reduced 49.88%	21,100 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $2.05 Million - $2.43 Million	42,100 New	42,100 $2.43 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $82.2 Million - $246 Million	-2,240,000 Reduced 85.17%	390,000 $15.1 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $82.8 Million - $111 Million	2,350,000 Added 839.29%	2,630,000 $98 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $10.7 Million - $11.8 Million	262,200 Added 1473.03%	280,000 $12.4 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $686,724 - $787,472	17,800 New	17,800 $761,000
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $3.53 Million - $3.97 Million	-100,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $6.63 Million - $8.39 Million	-200,000 Reduced 66.67%	100,000 $3.6 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $5.17 Million - $6.33 Million	150,000 Added 100.0%	300,000 $11.5 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $4.53 Million - $5.87 Million	150,000 New	150,000 $5.27 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $15.1 Million - $18.5 Million	-475,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $1.48 Million - $1.74 Million	45,000 Added 10.47%	475,000 $17.8 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $11.5 Million - $14.8 Million	430,000 New	430,000 $14.1 Million

1,541

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.